The filing excerpts provided do not contain sufficient substantive business information about MannKind Corp (NASDAQ: MNKD) to construct a SEC-grounded canonical description. The excerpts consist entirely of boilerplate SEC cover page language and do not disclose the company's business activities, revenue model, products, customers, competitors, geographic footprint, or financial figures. No supported description can be written from the available source material.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: Arcellx Inc TG Therapeutics Inc IGM Biosciences, Inc. Mirum Pharmaceuticals Inc Northwest Biotherapeutics Inc Viridian Therapeutics Inc Replimune Group Inc Sangamo Therapeutics Inc Seres Therapeutics Inc